Hepatitis C

New Project Funded By Nci, Nida, Aims To Eradicate Hepatitis C In Eastern Ky. County

With $15 million from the National Cancer Institute and National Institute on Drug Abuse and a donation of 900 doses of a 12-week treatment from Gilead Sciences Inc., University of Kentucky's Jennifer Havens has the goal of eradicating HCV in Perry...
Related topics: Hepatitis, National Institute On Drug Abuse, Cancer, Oncology, Medical Research

Read More →

Is It Finally Time To Buy Gilead Sciences?

In 2014, Gilead Sciences (NASDAQ: GILD) revolutionized hepatitis C treatment with a new class of drugs that functionally cured the disease, virtually eliminating the risk of life-threatening liver failure. The drugs were so game-changing that they...
Related topics: Nasdaq, Hepatitis, Liver Disease

Read More →

Fda Approves Mavyret For Children, Adolescents With Hep C

WEDNESDAY, May 1, 2019 -- Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17 years, the U.S. Food and Drug Administration announced yesterday. The FDA...
Related topics: Food And Drug Administration, Hepatitis, Virus, Virology

Read More →

Fda Approves Two-drug Combo Mavyret For Hcv In Adolescents

The FDA approved glecaprevir and pibrentasvir (Mavyret, AbbVie) tablets for the treatment of all six hepatitis C virus (HCV) genotypes in children ages 12 to 17 years. FDA Approvals
Related topics: Food And Drug Administration, Hepatitis, Virus, Virology

Read More →

Judge Orders Florida To Start Treating Inmates Who Have Hepatitis C

The state was reportedly neglecting to treat patients with the disease due to the cost of the drugs that cure it.
Related topics: Hepatitis

Read More →

Lungs, Hearts Infected With Hepatitis C Still Ok For Transplant

WEDNESDAY, April 3, 2019 -- Patients in dire need of an organ transplant can safely receive a new heart or lung from donors who have hepatitis C, a new clinical trial has shown. By swiftly administering powerful antiviral drugs, doctors can...
Related topics: Hepatitis, Clinical Trials

Read More →

New Study Identifies Genetic Variant That Could Help Reduce Need For Liver Transplants

A new study has identified a genetic variant associated with liver fibrosis (scarring) in chronic hepatitis C patients. This finding is a step toward reducing the number of patients requiring liver transplants.
Related topics: Medical Research, Genetics, Hepatitis

Read More →

Hbv, Hcv Control Aids Kidney Transplant Outcomes

MONDAY, March 25, 2019 -- The outcomes of kidney transplants in patients with viral suppression are as good as those for kidney transplants in patients not infected with hepatitis B virus (HBV) or hepatitis C virus (HCV), according to a study...
Related topics: Viral Hepatitis, Hepatitis, Hepatitis B, Virus, Virology, Medical Research

Read More →

New Hepatitis C Cases Down By Almost 70 Percent In Hiv-positive Men In London

New cases of hepatitis C amongst HIV-positive men in London have fallen by nearly 70 percent in recent years. The new analysis of data from three clinics in London found 256 men were diagnosed between 2013-2018. New infections peaked at 17 for every...
Related topics: Hepatitis, HIV, Virus

Read More →

Can The Netflix Model Eliminate The Most Infectious Disease In America?

Louisiana and Washington want to pay a flat fee to hepatitis C drug makers, such as Gilead, AbbVie and Merck, for unlimited meds each year.
Related topics: Hepatitis, Merck & Co

Read More →

Doctors Eradicate Hepatitis C In Patients After Heart Transplants From Infected Donors

Nine patients have recently been cured of the Hepatitis C virus (HCV) following lifesaving heart transplants from deceased donors who were infected with the disease, according to a new study. The results highlight the potential for expanding the use...
Related topics: Hepatitis, Cardiovascular Disease, Virus, Virology, Medical Research

Read More →

New Hepatitis Meds Are Saving Lives: Study

TUESDAY, Feb. 12, 2019 -- New (and pricey) hepatitis C medicines, such as Harvoni and Sovaldi, are living up to their promise and greatly reducing patients' odds for liver cancer and death, a new French study finds. The news came as little...
Related topics: Hepatitis, Medical Research, Liver Cancer, Cancer, Oncology

Read More →

Direct-acting Antivirals Cut Mortality In Chronic Hepatitis C

TUESDAY, Feb. 12, 2019 -- For adults with chronic hepatitis C virus (HCV) infection, direct-acting antivirals are associated with a reduced risk for mortality and hepatocellular carcinoma, according to a study published online Feb. 11 in The...
Related topics: Hepatitis, Virus, Virology, Hepatocellular Carcinoma, Medical Research

Read More →

New Hepatitis Meds, Such As Harvoni And Sovaldi, Are Saving Lives: Study

TUESDAY, Feb. 12, 2019 -- New (and pricey) hepatitis C medicines, such as Harvoni and Sovaldi, are living up to their promise and greatly reducing patients' odds for liver cancer and death, a new French study finds. The news came as little...
Related topics: Hepatitis, Medical Research, Liver Cancer, Cancer, Oncology

Read More →

Why The Us Has Higher Drug Prices Than Other Countries

Spending on pharmaceuticals is on the rise worldwide. And it well should be. Today, we are able to cure some diseases like hepatitis C that were virtual death sentences just a few years ago. This progress required significant investments by...
Related topics: Hepatitis

Read More →

Hepatitis C Infection Rates Up After Oxycontin Reformulation

WEDNESDAY, Feb. 6, 2019 -- States with above-median OxyContin misuse before reformulation of the drug experienced a 222 percent increase in hepatitis C infection rates after reformulation, according to a report published in the February issue of...
Related topics: Hepatitis

Read More →

Add Hepatitis C To The List Of Unintended Consequences Of Abuse-deterrent Opioids

One year ago Cato published my policy analysis, “Abuse-Deterrent Opioids and the Law of Unintended Consequences,” which provided strong evidence that reformulating opioids, so that they could not be crushed for snorting or dissolved for...
Related topics: Hepatitis

Read More →

Gilead Sciences' Hcv Albatross Weighs On Its Results Yet Again

HIV sales up, hepatitis C virus (HCV) sales down. That was the story for Gilead Sciences (NASDAQ: GILD) when the big biotech reported its third-quarter results in October. And it's been the story for Gilead for a while.Gilead announced its...
Related topics: HIV, Virus, Hepatitis, Virology, Nasdaq

Read More →

Abuse-deterrent Oxycontin Tied To Spike In Hepatitis C

The introduction of abuse-deterrent OxyContin may be a factor in the sharp rise in hepatitis C infections in the United States because drug abusers switched to injectable heroin, research suggests. News Alerts
Related topics: Hepatitis, Medical Research

Read More →

Progress Against Hepatitis C By 2030 Is Possible

A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 -- equal to an 80 percent reduction in incidence and...
Related topics: Hepatitis, Cirrhosis, Liver Cancer, Cancer, Oncology

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.